The pharmacy is accredited and I have verified that on the accreditor register.
I am trying to do this correctly the first time rather than learn it by getting it wrong.
I have already made one mistake here that cost me a vial, so I am being deliberately careful.
What is the correct sequence, and where is the step that people usually skip?
Answering this needs the plan, since criteria vary and a general answer is not actionable.
Where prerequisite therapy is required, the record needs the agent, the dates, the dose and the reason it was stopped. "Tried and failed" without those four elements is not documentation.
Submit the supporting documents with the request rather than waiting to be asked. Requests denied for insufficient information are denials that a complete submission would have avoided.
Appeal windows and renewal periods are defined in plan documents and are strictly applied.
The denial reason is the appeal specification. Address it directly.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsSpecifically, this is a paperwork problem with a paperwork solution, and framing it that way is the most useful thing anyone can do.
Each criterion must be evidenced in the clinical record, dated, before the request. A criterion asserted in a covering letter but absent from the notes is the commonest reason for a denial.
Track the deadlines. Appeal windows are finite, and a well-founded appeal filed late is worth nothing at all.
Processes differ by jurisdiction and by plan, so any general description will be wrong somewhere.
Get the criteria first. A request written blind is a request written badly.
Start by obtaining the criteria before the request is submitted, because a request written blind is a request written badly.
Approvals expire. Note the renewal date when the approval arrives, because a lapse mid-treatment is administratively identical to a fresh denial.
Put another way, the denial letter states a specific reason. The appeal should address that reason first and explicitly, with the missing evidence attached, rather than restating the original case.
Research-use compounds are outside this framework entirely and are not approved for human use.
Diarise the renewal date the moment approval arrives.
The denial letter states the reason. That reason is the specification for the appeal.
A peer-to-peer review — the prescriber speaking to the plan's reviewer — is available in many systems and resolves a meaningful proportion of denials that a written appeal would not.
Medical policies stating prior-authorisation criteria are published by plans and are obtainable before submission.
Attach everything on the first submission. Incomplete is the commonest denial.
edited 19 Jan 2026 by hana_petrikova — removed a claim I could not source
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.